DRKS00030687尚未招募不适用
The observational Post-Market Clinical Follow-up activity with the dialysis catheters P-DLS from Joline GmbH & Co.KG.
Joline GmbH & Co. KG0 个研究点目标入组 115 人开始时间: 2022年11月17日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 115
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- one 至 14 Years（—）
- 性别
- All
入选标准
- •Clinical indication for extracorporeal blood purification and therefore the need for temporary vascular access.
- •-Decision of the physician to use the CE-marked dialysis catheter ST (P-DLS) according to the indications written in the instructions for use.
- •-A signed informed consent form
排除标准
- •Patients with contraindications according to the instructions for use.
- •-occluded or thrombosed vessels
- •-Known allergic disposition to the material of the dialysis catheter
研究者
相似试验
招募中
不适用
Post-Market Clinical Follow-up Observational Study of the ORIGIN® Total Knee Prosthesis and ORIGIN® Single-Use InstrumentsPatients requiring total knee replacement.• Patients with severe painful and/or disabled knee joint, resulting from:• Non-inflammatory degenerative knee joint disease:Osteoarthritis, necrosis, post traumatic arthritis• Inflammatory knee joint disease:Rheumatoid arthritisDRKS00029551Symbios Orthopédie SA172
已完成
不适用
A Prospective Post Market Clinical Follow Up Investigation to Evaluate and Compare Performance of the HOYA Vivinex Impress™ Monofocal Preloaded IOL with Alcon AcrySof® IQ IOH25Senile cataractDRKS00026617HOYA Surgical Optics GmbH184
已完成
4 期
The purpose of the study is to evaluate safety and performance of Preservative Free Eye Preparations - Preservative Free Eye Drops with Calendula and Hamamelis extractCTRI/2022/07/043861Stericon Pharma Private Limited144
已完成
4 期
the study is to evaluate safety and performance of Preservative Free Eye Preparations - Preservative Free Eye Drops with Chamomile and Euphrasia extractCTRI/2022/07/043860Stericon Pharma Private Limited144
已完成
不适用
on-interventional Post-Market Clinical Follow-up Study to endorse performance and safety of Weiche Nasensalbe nach Dr. Bader® for moistening the dry nasal mucosa in the anterior area of the noseDry nose and/or nasal mucosaDRKS00032964Hälsa Pharma GmbH50